Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Holden

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosisRuth Dobson, David Holden, Nicola Vickaryous, et al.
Pain Medicine (Malden, Mass.)|February 9, 2021
Opioid Overdose Risk in Patients Returning to the Emergency Department for PainSophia Sheikh, Ashley Booth-Norse, David Holden, et al.
Acta Crystallographica. Section D, Biological Crystallography|May 31, 2002
The three-dimensional structure of calcium-depleted human C-reactive protein from perfectly twinned crystalsMohamed A M Ramadan, Annette K Shrive, David Holden, et al.
Microbiology (Reading, England)|February 7, 2001
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infectionJun Yu, Alexander P Bryant, Andrea Marra, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 23, 2020
CSF neurofilament light chain testing as an aid to determine treatment strategies in MSSaúl Reyes, Ide Smets, David Holden, et al.
Annals of Intensive Care|May 21, 2021
Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsisFaheem W Guirgis, Christiaan Leeuwenburgh, Lyle Moldawer, et al.
Methods in Enzymology|June 29, 2010
Real-time DNA sequencing from single polymerase moleculesJonas Korlach, Keith P Bjornson, Bidhan P Chaudhuri, et al.
Multiple Sclerosis and Related Disorders|December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational studyIde Smets, David Holden, Lucia Bianchi, et al.
Multiple Sclerosis and Related Disorders|July 11, 2018
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE studyJulian Gold, Monica Marta, Ute C Meier, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cellsFrancesca Ammoscato, Mohammad Wafa, Justyna Skonieczna, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosisRuth Dobson, David Holden, Nicola Vickaryous, et al.
Pain Medicine (Malden, Mass.)|February 9, 2021
Opioid Overdose Risk in Patients Returning to the Emergency Department for PainSophia Sheikh, Ashley Booth-Norse, David Holden, et al.
Acta Crystallographica. Section D, Biological Crystallography|May 31, 2002
The three-dimensional structure of calcium-depleted human C-reactive protein from perfectly twinned crystalsMohamed A M Ramadan, Annette K Shrive, David Holden, et al.
Microbiology (Reading, England)|February 7, 2001
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infectionJun Yu, Alexander P Bryant, Andrea Marra, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 23, 2020
CSF neurofilament light chain testing as an aid to determine treatment strategies in MSSaúl Reyes, Ide Smets, David Holden, et al.
Annals of Intensive Care|May 21, 2021
Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsisFaheem W Guirgis, Christiaan Leeuwenburgh, Lyle Moldawer, et al.
Methods in Enzymology|June 29, 2010
Real-time DNA sequencing from single polymerase moleculesJonas Korlach, Keith P Bjornson, Bidhan P Chaudhuri, et al.
Multiple Sclerosis and Related Disorders|December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational studyIde Smets, David Holden, Lucia Bianchi, et al.
Multiple Sclerosis and Related Disorders|July 11, 2018
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE studyJulian Gold, Monica Marta, Ute C Meier, et al.
Clinical Immunology (Orlando, Fla.)|October 20, 2024
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cellsFrancesca Ammoscato, Mohammad Wafa, Justyna Skonieczna, et al.
Pageof 3